Can Exercise Improve Swallowing for ALS Patients?
In this video from the American Speech-Language-Hearing Association, watch the interview “Behind the Science” with Emily Plowman, PhD from University of Florida, where she discusses the…
In this video from the American Speech-Language-Hearing Association, watch the interview “Behind the Science” with Emily Plowman, PhD from University of Florida, where she discusses the…
An after-school study by two teenagers in Canada found that maple syrup protects neurons and halts the development of amyotrophic lateral sclerosis (ALS) in an animal model of the disease. While the study was intended for educational purposes, its discoveries that might be of interest to drug developers. The students, Catherine Aaron and…
AB Science recently reported positive data from an interim analysis of a Phase 2/3 study of masitinib, its lead compound to treat amyotrophic lateral sclerosis (ALS).  The company also held a web conference with leading ALS experts on April 8, followed by a report summarizing the ongoing trial. Masitinib is a…
Molecular Stethoscope, Inc., announced it is working with 23 U.S. academic and medical institutions to further validate its blood-based early diagnostic and disease monitoring tests for hard-to-detect conditions, including amyotrophic lateral sclerosis (ALS) . The San Diego, California-based, company has developed proprietary technology that uses circulating cell-free RNA (ribonucleic acid) in the blood to…
Researchers created a mobile cart device allowing people to communicate via laptops by eye movement alone. The device was designed with severely disabled tetraplegic patients in mind, but it may also help those with decreased upper extremity and hand function, like that caused by amyotrophic lateral sclerosis (ALS), to more easily work with a computer. Shannon…
In this video from Rare Disease Report, watch Dr. Shafeeq S. Ladha, from Barrow Neurological Institute in Phoenix, Arizona talk “about the numerous amyotrophic lateral sclerosis (ALS studies) they have underway at the institute.” Read the latest updates on ALS: https://bit.ly/ALSNewsToday…
Origent Data Sciences, Inc., and Cytokinetics, Inc., announced a new research partnership to further refine and validate an Origent computer model to predict the progression of amyotrophic lateral sclerosis (ALS) in patients — a progression that widely varies, making effective clinical trials difficult and costly — by leveraging data from previous and…
In this video from the Mayo Clinic, watch Dr. Leonard Petrucelli talk about how the clinic has been studying and researching for a new development of a mouse model “that exhibits the features linked with the most common genetic form of ALS and frontotemporal dementia.” Read…
AB Science announced that its Phase 2/3 clinical trial evaluating masitinib, the company’s lead compound to treat amyotrophic lateral sclerosis (ALS) patients, has met its primary objective. The ongoing study is currently recruiting participants and expects to finish in June 2017. “The positive outcome of this study in ALS is a significant milestone…
In this ALS Association video watch specialists in ALS care explore the choices available for respiratory support. Learn more about ALS here: https://bit.ly/ALSNewsToday ALS News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is…
Get regular updates to your inbox.